[EN] SUBSTITUTED PYRIDAZINONE FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES<br/>[FR] PYRIDAZINONE SUBSTITUÉE DESTINÉE À ÊTRE UTILISÉE DANS LE TRAITEMENT DE MALADIES NEUROMUSCULAIRES
申请人:EDGEWISE THERAPEUTICS INC
公开号:WO2021231615A1
公开(公告)日:2021-11-18
Substituted pyridazinone compounds, conjugates, and pharmaceutical compositions for use in the treatment of neuromuscular diseases, such as Duchenne Muscular Dystrophy (DMD), are disclosed herein. The disclosed compounds are useful, among other things, in the treating of DMD and modulating inflammatory inhibitors IL-1, IL-6 or TNF-α.
AN ISOTOPIC STUDY OF THE REDUCING ACTION OF THE GRIGNARD REAGENT
作者:G. E. Dunn、John Warkentin
DOI:10.1139/v56-007
日期:1956.1.1
Benzophenone has been reduced to benzhydrol with three samples of isobutylmagnesium bromide containing deuterium in the alpha, beta, and gamma positions, respectively. Deuterium was found only in the benzhydrol obtained from β-deuteroisobutylmagnesium bromide. Comparison of the ratios of deuterium to protium in β-deuteroisobutylmagnesium bromide and in the benzhydrol obtained from it shows an isotope